Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | XTNT | Common Stock | Award | $0 | +243K | +3.91% | $0.00 | 6.46M | Aug 15, 2024 | Direct | F1, F2 |
transaction | XTNT | Common Stock | Award | $0 | +505K | +7.83% | $0.00 | 6.96M | Aug 15, 2024 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | These shares are subject to a deferred stock unit award granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan, and vest on August 15, 2025, conditioned upon the Reporting Person remaining a director of Xtant through the respective vesting date. |
F2 | Includes 966,418 shares issuable upon settlement of deferred stock units granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining a director of Xtant through the respective vesting dates. |